A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Generally cloudy with fairly persistent rain through this evening, but the cloud and rain will break up overnight with drier conditions.
Wales fans are continuing to celebrate yesterday's historic Euro 2016 win over Northern Ireland, which sees them make the quarter finals.
A lot has happened in the days since the Brexit result. We've been asking people how they're feeling about the fallout of the referendum.